ADIPOQ and fatty liver disease: Fatty liver pathogenesis is associated with elevated liver AOX1 [37], while adiponectin can inhibit the expression of AOX1 by activating PPARɑ, therefore enhancing the lipid oxidation, attenuating the inflammation reaction and alleviating the liver injuries [22].